In this pilot study, we demonstrated that serum biomarkers GP73 and LG2m, when combined with age and sex to create the GLAS algorithm, showed superior sensitivity and specificity for detection of liver fibrosis and cirrhosis. The gene discussed is GOLM1; the disease is Cirrhosis.